Corporate News 11-Feb-22
Alkem signs license agreement with Harvard University's Office of Technology Development
Alkem Laboratories has signed a license agreement with Harvard University's Office of Technology Development (OTD) enabling Alkem to develop and commercialize a novel technology that may help meet the dire need for effective treatment of diabetic neuropathy, foot ulcers, peripheral arterial disease (PAD), and other injuries caused by vascular disease. The license grants Alkem commercialization rights in the United States and India.
Previous News
Alkem Laboratories consolidated net profit declines 34.02% in the March 2023 quarter
( Results - Announcements 19-May-23 14:16 )
Alkem Laboratories to convene AGM
( Corporate News - 28-Jun-24 19:25 )
Alkem Laboratories fixes record date for final dividend
( Market Beat - Reports 19-May-23 14:05 )
Alkem Lab sells US based plant to New Mill Capital Holdings
( Hot Pursuit - 30-Dec-23 15:19 )
Alkem Labs appoints Dr. Vikas Gupta as CEO
( Hot Pursuit - 15-Sep-23 12:45 )
Alkem Laboratories
( Results - Analysis 11-Feb-23 21:38 )
Alkem Lab Q4 PAT drops 34% YoY to Rs 71 cr
( Hot Pursuit - 19-May-23 14:59 )
Alkem Lab gains as Indore facility gets EIR from USFDA
( Hot Pursuit - 24-Feb-23 09:46 )
Alkem Laboratories announces board meeting date
( Corporate News - 01-Aug-23 10:20 )
Alkem Laboratories
( Results - Analysis 30-May-24 10:39 )
Alkem Laboratories Ltd gains for third straight session
( Hot Pursuit - 09-Mar-22 13:05 )
Other Stories
Tridhya Tech to convene board meeting
03-Jul-24 20:06
Sonu Infratech schedules EGM
03-Jul-24 19:59
Sakuma Exports to convene AGM
03-Jul-24 19:59
Time Technoplast repays commercial paper
03-Jul-24 18:31
Board of Aditya Vision approves stock split and listing of share on NSE
03-Jul-24 18:24
Pricol director resigns
03-Jul-24 18:21
Board of VMS Industries recommends first interim dividend
03-Jul-24 17:49
Lakshmi Machine Works to declare Quarterly Result
03-Jul-24 17:44
Modison to convene AGM
03-Jul-24 17:43
Sybly Industries to discuss results
03-Jul-24 17:43
Back
Top